IP Library Granted Patent US 10,682,318
Granted Patent B2
US 10,682,318 · App. 16/449,361 · Granted Jun 16, 2020

Materials and methods for controlling infections

Inventors: Carolyn L. Twomey (Lawrenceville, GA); Gareth Clarke (Lawrenceville, GA); Samuel Zaidspiner (Lawrenceville, GA)
Assignee: INNOVATION TECHNOLOGIES, INC.
A61K31/155A61F13/00063A61K9/0019A61K9/0043A61K9/0073A61K9/0085A61K9/08A61K31/191A61K45/06A61L15/44A61L17/005A61L27/54A61L29/08A61L29/16A61L31/08A61L31/16A61M25/0017A61K2300/00A61L2300/206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,682,318
App. No.
16/449,361
Granted
Jun 16, 2020
Kind
B2
Abstract

The subject invention provides materials methods for reducing infections in subjects. The materials methods utilize chlorhexidine, which has been found to be surprisingly non-toxic. The lack of toxicity facilitates the use of chlorhexidine in contexts that were not previously thought to be possible.

Claims (6)

1. A method for treating a biofilm infection at a chronic wound site or a burn wound site of a subject wherein said method comprises administering to the site a solution comprising chlorhexidine at a concentration of 0.1% or less, wherein said method further comprises applying suction to the site, wherein the chlorhexidine is chlorhexidine gluconate (CHG), wherein the solution consists essentially of an aqueous solution of CHG, wherein the vascular system of the subject is exposed to said solution, and wherein said method results in the inhibition of growth of biofilm that is present at the wound.

2. The method, according to claim 1 , wherein the concentration of CHG is 0.05% or less.

3. The method, according to claim 1 , wherein suction is applied 5 minutes or less after the administration of CHG.

4. The method, according to claim 1 , wherein the site is a site of healing tissue.

5. The method, according to claim 1 , wherein the site is a chronic wound.

6. The method, according to claim 1 , wherein the site is a burn wound.

Assignments (2)
SECURITY INTEREST Recorded Aug 21, 2024
From: INNOVATION TECHNOLOGIES, INC.
To: OXFORD FINANCE LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 068360/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2019
From: TWOMEY, CAROLYN L.; CLARKE, GARETH; ZAIDSPINER, SAMUEL
To: INNOVATION TECHNOLOGIES, INC.
Reel/Frame 049771/0542 →
Continuity (8)
Continuation 15942471 · Mar 31, 2018
Continuation 15803255 · Nov 3, 2017
Continuation 15803279 · Nov 3, 2017
Continuation 15173089 · Jun 3, 2016
Continuation 15168176 · May 30, 2016
Continuation 14568925 · Dec 12, 2014
Provisional Application 61915281 · Dec 12, 2013
Related Publication 20190307709A1 · Oct 10, 2019
Cited By (2)
US 12,290,655 US 12,458,540